Lobbyist information

Amount

Anthony J Magnetti

$12,154.15

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2016 Any and all legislation and regulations pertaining to healthcare systems. Any issue that impacts a biopharmaceutical company's ability to market or sell its products in all sectors/markets in the Commonwealth; any laws or regulations that impose or levy taxes upon a biopharmaceutical company doing business in the Commonwealth; any laws or regulations which provided incentives or disincentives to biopharmaceutical companies conducting research and development in the Commonwealth; and, any policy or proposal that seeks to limit or restrict unfettered patient access to innovative medicines and therapies in the Commonwealth's Medicaid or other publicly funded and reimbursed programs; any legislation or regulations related to payment reform, recycling and disposal policies, provider and industry practices related to pharmaceuticals, drug pricing, drug transparency, prescribing, dispensing, and monitoring controlled substances and related policies, mental health and epilepsy patient access and prescribing related policies, drug safety. Any and all legislation, regulation, policy matters pending before the legislature or executive branch including not limited to Executive Office of Health and Human Services, Department of Public Safety, Division of Insurance, Medicaid, Department of Mental Health, and Health Policy Commission.

Katrina Iserman

$2,167.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2016 Any and all legislation and regulations pertaining to healthcare systems. Any issue that impacts a biopharmaceutical company's ability to market or sell its products in all sectors/markets in the Commonwealth; any laws or regulations that impose or levy taxes upon a biopharmaceutical company doing business in the Commonwealth; any laws or regulations which provided incentives or disincentives to biopharmaceutical companies conducting research and development in the Commonwealth; and, any policy or proposal that seeks to limit or restrict unfettered patient access to innovative medicines and therapies in the Commonwealth's Medicaid or other publicly funded and reimbursed programs; any legislation or regulations related to payment reform, recycling and disposal policies, provider and industry practices related to pharmaceuticals, drug pricing, drug transparency, prescribing, dispensing, and monitoring controlled substances and related policies, mental health and epilepsy patient access and prescribing related policies, drug safety. Any and all legislation, regulation, policy matters pending before the legislature or executive branch including not limited to Executive Office of Health and Human Services, Department of Public Safety, Division of Insurance, Medicaid, Department of Mental Health, and Health Policy Commission.

Keith S Osburn

$0.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2016 09/26/2016 All issues and regulations related to payment reform, pharmaceuticals, recycling and disposal policies, provider and industry practices related to pharmaceuticals, prescribing, dispensing, and monitoring controlled substances and related policies, mental health patient access and prescribing related policies, research and development, taxation policies, drug safety

Total salaries paid:      $14,321.15

Lobbyist Entity information

Amount

McDermott, Quilty & Miller, LLP	$59,225.00
Employed Terminated 01/01/2016

Total salaries paid:      $59,225.00

Expenditures

Amount